Market Snapshot

BSE Sensex: 76664.21 -1.29%
BSE 500: 35349.66 -1.06%
BSE 200: 11074.32 -1.05%
BSE 100: 25300.66 -1.08%
BSE BANKEX: 63188.31 -0.44%
BSE IT: 27648.74 -5.13%
Nifty 50: 23897.95 -1.14%
Nifty 500: 22570.05 -1.06%
Nifty 200: 13656.85 -1.05%
Nifty 100: 24827.3 -1.07%
Nifty Midcap 100: 59374.8 -0.96%
Nifty Small 100: 17567.2 -0.87%
Nifty IT: 28530.6 -5.29%
Nifty PSU Bank: 8811.2 -0.15%

News:

Mahindra Finance Q4 PAT climbs...
L&T Finance Q4 PAT jumps 27% Y...
Paytm Payments Bank licence ca...
Reliance Industries Q4 profit ...
Indusind Bank reports turnarou...

Epigral Ltd Share Price – NSE / BSE
Chemicals, Small Cap

Invest

24 Apr 2026 | 03:59 PM

1,199.60

7.15 (0.60%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-37.31%

Return (1Y)

Underperformed BSE Commodities by 52.07%
More Volatile

2.39%

Standard Deviation (1Y)

Higher than BSE Commodities by 1.26%
Inconsistent Performer

3/12

Months

underperformed BSE Commodities
AxisDirect View

No View

52 Week High-Low

2,114

806

News & Announcements

Epigral consolidated net profit declines 62.26% in the December 2025 quarter
85 days ago

Epigral consolidated net profit declines 62.26% in the December 2025 quarter

30 - Jan - 2026 12:00 | 85 days ago

Net profit of Epigral declined 62.26% to Rs 39.11 crore in the quarter ended December 2025 as against Rs 103.63 crore during the previous quarter ended December 2024. Sales declined 7.46% to Rs 597.12 crore in the quarter ended December 2025 as against Rs 645.24 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 597.12 645.24 -7

OPM % 17.20 28.29 -

PBDT 97.31 186.53 -48

PBT 54.56 153.62 -64

NP 39.11 103.63 -62

Powered by Capital Market - Live News
Epigral to declare Quarterly Results
95 days ago

Epigral to declare Quarterly Results

20 - Jan - 2026 12:00 | 95 days ago

Epigral will hold a meeting of the Board of Directors of the Company on 30 January 2026.
Powered by Capital Market - Live News
Epigral slides after receiving Rs 53-cr income tax demand notice
113 days ago

Epigral slides after receiving Rs 53-cr income tax demand notice

02 - Jan - 2026 12:00 | 113 days ago

In an exchange filing, the company said the assessment order pertains to Assessment Year 2022?23, corresponding to Financial Year 2021?22. The order was passed under Section 143(3) read with Section 144C(13) of the Income-tax Act, 1961, along with a notice of demand issued under Section 156 of the Act, including applicable interest.
Epigral stated that the assessment order was issued in the ordinary course of assessment proceedings and that it has adequate factual and legal grounds to substantiate its position. The company added that there is no financial impact on its financials, operations, or other business activities arising from the order.
The company further said it believes the demand is not maintainable and is in the process of filing a rectification application and an appeal against the order within the prescribed timelines.
The company received the demand notice on 31 December 2025, while the official announcement was made on 1 January 2026, after market hours.
Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India. Epigral?s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure. In India, Epigral is the first to set up an epichlorohydrin plant and the largest capacity plant of CPVC. Epigral is also a leading manufacturer of caustic soda, caustic potash, chloromethanes, hydrogen peroxide, chlorine and hydrogen.
The company reported 36% fall in consolidated net profit to Rs 51 crore on a 7% fall in total revenue to Rs 589 crore in Q2 FY26 as compared with Q2 FY25.
Powered by Capital Market - Live News
Epigral consolidated net profit declines 37.00% in the September 2025 quarter
166 days ago

Epigral consolidated net profit declines 37.00% in the September 2025 quarter

10 - Nov - 2025 12:00 | 166 days ago

Net profit of Epigral declined 37.00% to Rs 51.22 crore in the quarter ended September 2025 as against Rs 81.30 crore during the previous quarter ended September 2024. Sales declined 6.18% to Rs 587.36 crore in the quarter ended September 2025 as against Rs 626.06 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 587.36 626.06 -6

OPM % 22.48 28.50 -

PBDT 111.96 157.43 -29

PBT 69.65 125.18 -44

NP 51.22 81.30 -37

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Meghmani Finechem Ltd has decreased by -34.71% since past 3 Months
MF shareholding in Meghmani Finechem Ltd has decreased by -3.75% since past 3 Months
FII shareholding in Meghmani Finechem Ltd has decreased by -48.79% since past 1 Year
MF shareholding in Meghmani Finechem Ltd has increased by 9.51% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	597.12	645.24	-7
OPM %	17.20	28.29	-
PBDT	97.31	186.53	-48
PBT	54.56	153.62	-64
NP	39.11	103.63	-62

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	587.36	626.06	-6
OPM %	22.48	28.50	-
PBDT	111.96	157.43	-29
PBT	69.65	125.18	-44
NP	51.22	81.30	-37

General Notifications

My Notifications

Research Notifications

Epigral Ltd Share Price – NSE / BSE Chemicals, Small Cap

1,199.60 7.15 (0.60%)

News & Announcements

Price vs Volume

Stock Trivia

Epigral Ltd Share Price – NSE / BSE
Chemicals, Small Cap

1,199.60

7.15 (0.60%)